Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Comparison of ketorolac dosing in an emergency department setting.
The "elusive DMOAD": Aggrecanase inhibition from laboratory to clinic.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The "elusive DMOAD": Aggrecanase inhibition from laboratory to clinic.
The "elusive DMOAD": Aggrecanase inhibition from laboratory to clinic. Clin Exp Rheumatol. 2019 Sep-Oct; 37 Suppl 120(5):130-134.
View in:
PubMed
subject areas
ADAM Proteins
ADAMTS4 Protein
Aggrecans
Endopeptidases
Humans
Osteoarthritis
Procollagen N-Endopeptidase
authors with profiles
Anne-Marie Malfait